CXCL1 is upregulated during the development of ileus resulting in decreased intestinal contractile activity.

Tibor Docsa, Deepa Bhattarai, Adam Sipos, Charles E Wade, Charles S Cox, Karen Uray

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2020 Mar

filter terms:

Although the development of ileus is widespread and negatively impacts patient outcomes, the mechanism by which ileus develops remains unclear. The purpose of our study was to examine the contribution of myogenic mechanisms to postoperative ileus development and the involvement of inflammation in mediating intestinal smooth muscle dysfunction. Contractile activity and the effects of CXCL1 were studied in a gut manipulation model. Contraction amplitude in the ileum decreased significantly, while tone increased significantly in response to gut manipulation. Differences in contraction amplitude were affected by tetrodotoxin at earlier time points, but not at later time points. Agonist-induced contractions in the small intestine decreased significantly with ileus development. Intestinal transit slowed significantly after the induction of ileus. Myosin light chain phosphorylation was significantly decreased and edema increased significantly in the intestinal wall. Conditioned media from mechanically activated macrophages depressed intestinal contractile activity. CXCL1 (GroA) was significantly increased in the mechanically activated macrophages and intestinal smooth muscle within 1 hour after induction of ileus compared with control cells and sham animals, respectively. Treatment with CXCL1 significantly decreased contraction amplitude and agonist-induced contractile activity and increased tone in the small intestine. In the gut manipulation model, treatment with a CXCR2 antagonist prevented the decrease in agonist-induced contractile activity but not contraction amplitude. These data suggest that CXCL1, released from macrophages during intestinal wall stress, can suppress intestinal contractile activity. CXCL1 is a potential target for preventing or treating ileus in trauma patients. © 2019 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.

Citation

Tibor Docsa, Deepa Bhattarai, Adam Sipos, Charles E Wade, Charles S Cox, Karen Uray. CXCL1 is upregulated during the development of ileus resulting in decreased intestinal contractile activity. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2020 Mar;32(3):e13757